AI Article Synopsis

  • - Fhit protein, often absent in many cancers, can be restored to suppress tumor growth and induce cell death (apoptosis) using viral gene therapy in experimental models.
  • - Research has identified a protein complex involving Fhit, Hsp60, and Hsp10 that supports Fhit stability and its role in the mitochondria, where it interacts with enzymes involved in cellular electron transfer.
  • - Restoring Fhit leads to increased levels of reactive oxygen species in lung cancer cells, promoting apoptosis under oxidative stress; however, cancer cells lacking Fhit can survive and sustain oxidative DNA damage, increasing mutation risks.

Article Abstract

Fhit protein is lost in most cancers, its restoration suppresses tumorigenicity, and virus-mediated FHIT gene therapy induces apoptosis and suppresses tumors in preclinical models. We have used protein cross-linking and proteomics methods to characterize a Fhit protein complex involved in triggering Fhit-mediated apoptosis. The complex includes Hsp60 and Hsp10 that mediate Fhit stability and may affect import into mitochondria, where it interacts with ferredoxin reductase, responsible for transferring electrons from NADPH to cytochrome P450 via ferredoxin. Viral-mediated Fhit restoration increases production of intracellular reactive oxygen species, followed by increased apoptosis of lung cancer cells under oxidative stress conditions; conversely, Fhit-negative cells escape apoptosis, carrying serious oxidative DNA damage that may contribute to an increased mutation rate. Characterization of Fhit interacting proteins has identified direct effectors of the Fhit-mediated apoptotic pathway that is lost in most cancers through loss of Fhit.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376222PMC
http://dx.doi.org/10.1074/jbc.M709062200DOI Listing

Publication Analysis

Top Keywords

fhit
8
ferredoxin reductase
8
reactive oxygen
8
oxygen species
8
cancer cells
8
fhit protein
8
lost cancers
8
apoptosis
5
fhit interaction
4
interaction ferredoxin
4

Similar Publications

FHIT is a fragile site tumor suppressor that is primarily inactivated upon tobacco smoking. FHIT loss is frequently observed in lung cancer, making it an important biomarker for the development of targeted therapy for lung cancer. Here, we report that inhibitors of glycogen synthase kinase 3 beta (GSK3β) and the homologous recombination DNA repair (HRR) pathway are synthetic lethal with FHIT loss in lung cancer.

View Article and Find Full Text PDF

The tumor suppressor fragile histidine triad (FHIT) is frequently lost in non-small cell lung cancer (NSCLC). We previously showed that a down-regulation of FHIT causes an up-regulation of the activity of HER2 associated to an epithelial-mesenchymal transition (EMT) and that lung tumor cells harboring a FHIT/pHER2 phenotype are sensitive to anti-HER2 drugs. Here, we sought to decipher the FHIT-regulated HER2 signaling pathway in NSCLC.

View Article and Find Full Text PDF
Article Synopsis
  • The Vitamin D Antenatal Asthma Reduction Trial (VDAART) studied children from 6 months to 8 years and found links between specific gene variants and children's body mass index.
  • These associations also connected microbiome characteristics tied to obesity with important lipids and amino acids.
  • The findings suggest that genetic factors play a role in influencing the microbiome during development and highlight potential biomarkers for childhood obesity and related health issues like insulin resistance and type 2 diabetes.
View Article and Find Full Text PDF

Detection of a novel DNA methylation marker panel for esophageal cancer diagnosis using circulating tumor DNA.

BMC Cancer

December 2024

Department of Molecular Pathology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No 127, Dongming Road, Zhengzhou, 450008, Henan, China.

Background: Esophageal cancer (ECa) is one of the most deadly cancers, with increasing incidence worldwide and poor prognosis. While endoscopy is recommended for the detection of ECa in high-risk individuals, it is not suitable for large-scale screening due to its invasiveness and inconvenience.

Methods: In this study, a novel gene methylation panel was developed for a blood-based test, and its diagnostic efficacy was evaluated using a cohort of 304 participants (203 cases, 101 controls).

View Article and Find Full Text PDF
Article Synopsis
  • Elevated fetal hemoglobin (HbF) can reduce disease severity in β hemoglobinopathies, and understanding its genetic basis may lead to personalized treatments.
  • A systematic review of GWAS studies identified 939 significant SNP-trait associations linked to HbF, focusing on genes primarily located on chromosomes 2, 6, and 11, among others.
  • The study emphasizes the need for further research on less frequently associated genetic loci and suggests a focus on diverse populations to improve therapeutic strategies for conditions like sickle cell disease and β-thalassemia.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!